Beyond Belviq: Reinventing Arena To Focus On Phase II Candidates

 
• By Mike Ward

Dr. Amit Munshi, new CEO of Arena Pharmaceuticals, has already made several changes in the company’s focus and direction as it reduces its commitment to Belviq. He talked to Mike Ward about progress to date.

Video interview
Arena's CEO Amit Munshi talks to Scrip at Biotech Showcase

More from Strategy

More from Business